Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Anargyrou K"'
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3bb976ff80b447b9a8f16d9cd7908710
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407
Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorates quality of life. There are very limited data in the literature for the effect of chemotherapy on bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fb3894c14cf407b26524176b851ca29d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105354
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105354
Introduction: Invasive candidiasis (IC) can be a life-threatening infection in immunocompromised patients, particularly those with cancer, hematologic diseases and/or hematopoietic stem cell transplantation (HSCT) recipients. The objective of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aaf2a2214e689b521b52596ce0dd4165
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105968
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105968
This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ninety-five patients with R/R HL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::69c4e1cdc6c7e2f9f8086fa1ea1455b3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086446
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086446
Autor:
Anargyrou, K.1, Paterakis, G.2, Boutsis, D.1, Politou, M.1, Papdhimitriou, S.I.3, Siakandaris, M.1, Vassiliadis, J.1, Androulakis, A.1, Meletis, J.1, Rombos, J.1, Tassiopoulou, A.3, Vaiopoulos, G.1
Publikováno v:
European Journal of Haematology. Oct2003, Vol. 71 Issue 4, p294. 5p.
Lenalidomide and dexamethasone (RD) is a standard of care for relapsed/refractory multiple myeloma (RRMM), but there is limited published data on its efficacy and safety in the "real world" (RW), according to the International Society of Pharmacoecon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9a97caf6ac576568df87837254eb09fd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127511
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127511
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Myelodysplastic syndromes (MDS) are a group of heterogeneous clonal stem cell (SC) disorders that mainly affect the elderly population. They are characterized by ineffective hematopoiesis which results in quantitative and qualitative cellular defects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e737e05470f7240ab1dac7a3b5b9ed51
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3090275
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3090275